EPZ-6438 (Tazemetostat)
EPZ-6438 是一种强效、选择性且口服生物利用度高的小分子抑制剂,专门针对 EZH2 酶活性。它能特异性地在 SMARCB1 缺失的 MRT 细胞中诱导凋亡和分化。
全国免运费, 顺丰次日达
重要通知:仅供研究使用。我们不向患者销售。
重要通知:仅供研究使用。我们不向患者销售。
Discription | EPZ-6438 is a potent, selective, and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity. It induces apoptosis and differentiation specifically in SMARCB1-deleted MRT cells. | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A12712 |
---|---|
分子式 | C34H44N4O4 |
分子量 | 572.74 |
CAS号 | 1403254-99-8 |
SMILES | CCN(C1CCOCC1)C2=CC(=CC(=C2C)C(=O)NCC3=C(C=C(NC3=O)C)C)C4=CC=C(C=C4)CN5CCOCC5 |
其他名称 | EPZ6438, EPZ 6438 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | Warmed: 4 mg/mL (6.98 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 4% DMSO+30% PEG 300+5% Tween 80+ddH2O | 2.3 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 17.46 mL | 87.3 mL | 174.6 mL |
0.5 mM | 3.49 mL | 17.46 mL | 34.92 mL |
1 mM | 1.75 mL | 8.73 mL | 17.46 mL |
5 mM | 0.35 mL | 1.75 mL | 3.49 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2